Upgrades:
American Express (NYSE:AXP) was upgraded by investment analysts at Edward Jones from a "hold" rating to a "buy" rating in a report issued on Monday, Briefing.com reports.
Several other equities analysts have also commented on the
company. Oppenheimer reaffirmed an "outperform" rating and issued a
$200.00 price target on shares of American Express in a research note on
Wednesday, March 23rd. Robert W. Baird reaffirmed a "neutral" rating
and issued a $175.00 price target on shares of American Express in a research
note on Tuesday, April 26th. StockNews.com initiated coverage on American
Express in a research note on Thursday, March 31st. They issued a
"hold" rating on the stock. Citigroup upped their price target on
American Express from $187.00 to $190.00 and gave the company a
"neutral" rating in a research note on Tuesday, April 26th. Finally,
Morgan Stanley boosted their price objective on American Express from $218.00
to $223.00 and gave the company an "overweight" rating in a report on
Monday, March 28th. One investment analyst has rated the stock with a sell
rating, fourteen have issued a hold rating and eight have issued a buy rating
to the stock. According to MarketBeat.com, American Express presently has a
consensus rating of "Hold" and a consensus target price of $192.26. Read
more …
ResMed (NYSE:RMD) was upgraded by research analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating in a report issued on Monday, The Fly reports.
A number of other equities research analysts have also
commented on RMD. Wolfe Research assumed coverage on ResMed in a research
report on Tuesday, April 5th. They issued an "outperform" rating and
a $280.00 target price on the stock. StockNews.com downgraded ResMed from a
"buy" rating to a "hold" rating in a report on Monday, May
2nd. Six analysts have rated the stock with a hold rating and nine have issued
a buy rating to the stock. According to MarketBeat.com, the company presently
has an average rating of "Buy" and an average target price of
$267.11.
Shares of RMD opened at $208.31 on Monday. The company has a
market cap of $30.47 billion, a PE ratio of 39.23, a P/E/G ratio of 2.31 and a
beta of 0.45. The business has a fifty day moving average of $217.93 and a 200
day moving average of $237.23. ResMed has a 52-week low of $189.40 and a
52-week high of $301.34. The company has a quick ratio of 1.56, a current ratio
of 2.55 and a debt-to-equity ratio of 0.20. Read
more …
AmerisourceBergen (NYSE:ABC) was upgraded by research analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating in a report released on Tuesday, Briefing.com reports. The brokerage presently has a $178.00 target price on the stock, up from their previous target price of $167.00. Deutsche Bank Aktiengesellschaft's target price would indicate a potential upside of 21.18% from the stock's current price.
Several other equities analysts have also weighed in on the
company. Morgan Stanley reduced their price objective on AmerisourceBergen from
$178.00 to $175.00 and set an "equal weight" rating on the stock in a
research note on Friday, May 27th. Evercore ISI reduced their price objective
on AmerisourceBergen to $165.00 in a research note on Friday. Barclays raised
AmerisourceBergen from an "equal weight" rating to an
"overweight" rating and lifted their price objective for the company
from $175.00 to $182.00 in a research note on Thursday, May 26th. Argus lifted
their price objective on AmerisourceBergen from $140.00 to $160.00 in a
research note on Monday, March 14th. Finally, Mizuho raised their target price
on AmerisourceBergen from $139.00 to $162.00 in a report on Thursday, May 5th.
Three research analysts have rated the stock with a hold rating, four have
given a buy rating and one has issued a strong buy rating to the company.
According to MarketBeat, the company currently has an average rating of
"Buy" and a consensus price target of $169.25. Read
more …
McKesson (NYSE:MCK) was upgraded by investment analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating in a note issued to investors on Tuesday, The Fly reports.
Several other brokerages have also recently weighed in on
MCK. Robert W. Baird raised their price target on shares of McKesson from
$352.00 to $380.00 in a research report on Friday, May 6th. Credit Suisse Group
raised their price target on shares of McKesson from $333.00 to $377.00 in a research
report on Wednesday, May 11th. Mizuho raised their price target on shares of
McKesson from $280.00 to $331.00 in a research report on Monday, May 9th.
StockNews.com initiated coverage on shares of McKesson in a research report on
Thursday, March 31st. They issued a "strong-buy" rating on the stock.
Finally, UBS Group raised their price target on shares of McKesson to $380.00
and gave the company a "hold" rating in a research report on
Thursday, May 19th. Two investment analysts have rated the stock with a hold
rating, ten have given a buy rating and one has issued a strong buy rating to
the company's stock. According to MarketBeat, McKesson currently has an average
rating of "Buy" and a consensus target price of $326.00. Read
more …
Evercore ISI upgraded shares of Exxon Mobil (NYSE:XOM) from an in-line rating to an outperform rating in a report released on Tuesday, MarketBeat reports. Evercore ISI currently has $120.00 price target on the oil and gas company’s stock, up from their prior price target of $88.00. The analysts noted that the move was a valuation call.
XOM has been the topic of a number of other reports. Royal
Bank of Canada raised Exxon Mobil from a sector perform rating to an outperform
rating and lifted their price target for the stock from $90.00 to $100.00 in a
research note on Thursday, April 21st. StockNews.com downgraded Exxon Mobil
from a buy rating to a hold rating in a research report on Monday, May 2nd. The
Goldman Sachs Group set a $91.00 price objective on Exxon Mobil in a research
report on Thursday, March 3rd. MKM Partners lifted their price objective on
Exxon Mobil from $81.00 to $84.00 and gave the stock a buy rating in a research
report on Monday, March 7th. Finally, Argus lifted their price objective on
Exxon Mobil from $92.00 to $104.00 in a research report on Monday, May 9th. Two
analysts have rated the stock with a sell rating, eleven have given a hold
rating, ten have given a buy rating and one has issued a strong buy rating to
the company’s stock. Based on data from MarketBeat.com, the company presently
has an average rating of Hold and a consensus target price of $87.44. Read
more …
Freeport-McMoRan (NYSE:FCX) was upgraded by equities research analysts at Credit Suisse Group from an "underperform" rating to a "neutral" rating in a research report issued on Thursday, The Fly reports. The brokerage presently has a $38.00 price target on the natural resource company's stock, up from their previous price target of $32.00. Credit Suisse Group's target price suggests a potential downside of 9.95% from the stock's previous close.
A number of other equities research analysts also recently
issued reports on FCX. Morgan Stanley reduced their price objective on shares
of Freeport-McMoRan from $43.00 to $39.00 and set an "equal weight"
rating on the stock in a research note on Monday, April 25th. Raymond James set
a $59.00 price objective on shares of Freeport-McMoRan and gave the stock an
"outperform" rating in a research note on Friday, April 22nd.
Jefferies Financial Group increased their target price on shares of
Freeport-McMoRan from $58.00 to $65.00 and gave the stock a "buy"
rating in a report on Thursday, March 24th. Royal Bank of Canada increased
their target price on shares of Freeport-McMoRan from $46.00 to $47.00 and gave
the stock a "sector perform" rating in a report on Friday, April
22nd. Finally, StockNews.com raised shares of Freeport-McMoRan from a
"hold" rating to a "buy" rating in a report on Tuesday,
April 5th. Two investment analysts have rated the stock with a sell rating, six
have given a hold rating and eight have issued a buy rating to the stock.
According to data from MarketBeat, the stock has a consensus rating of
"Hold" and an average target price of $47.21. Read
more …
Pentair (NYSE:PNR) was upgraded by equities research analysts at Barclays from an "underweight" rating to an "equal weight" rating in a note issued to investors on Thursday, The Fly reports.
Other equities analysts have also issued reports about the
stock. Cowen decreased their price objective on shares of Pentair from $85.00
to $75.00 and set an "outperform" rating for the company in a report
on Friday, April 22nd. The Goldman Sachs Group cut their price objective on shares
of Pentair from $89.00 to $77.00 and set a "buy" rating for the
company in a research report on Wednesday, April 13th. Zacks Investment
Research raised shares of Pentair from a "sell" rating to a
"hold" rating and set a $57.00 target price for the company in a
report on Tuesday, April 12th. Mizuho raised shares of Pentair from an
"underperform" rating to a "neutral" rating and increased
their price objective for the company from $60.00 to $62.00 in a report on
Friday, March 4th. Finally, Morgan Stanley decreased their target price on
shares of Pentair from $50.00 to $49.00 and set an "underweight"
rating on the stock in a research report on Tuesday, May 31st. Two investment
analysts have rated the stock with a sell rating, ten have issued a hold rating
and nine have given a buy rating to the stock. According to MarketBeat.com, the
company presently has a consensus rating of "Hold" and an average
target price of $73.53. Read
more …
CME Group (NASDAQ:CME) was upgraded by investment analysts at Atlantic Securities from a "neutral" rating to an "overweight" rating in a note issued to investors on Friday, Briefing.com reports. The brokerage presently has a $235.00 target price on the financial services provider's stock. Atlantic Securities' target price suggests a potential upside of 18.73% from the company's previous close.
CME has been the topic of a number of other reports. Morgan
Stanley raised their price objective on shares of CME Group from $255.00 to
$271.00 and gave the stock an "equal weight" rating in a report on
Wednesday, April 13th. JPMorgan Chase & Co. dropped their price objective
on shares of CME Group from $202.00 to $201.00 and set a "neutral"
rating on the stock in a report on Thursday, February 10th. StockNews.com
assumed coverage on shares of CME Group in a research report on Thursday, March
31st. They issued a "hold" rating for the company. Credit Suisse
Group decreased their target price on shares of CME Group from $265.00 to
$262.00 and set a "neutral" rating for the company in a research
report on Tuesday, April 5th. Finally, Rosenblatt Securities reduced their
target price on shares of CME Group from $268.00 to $267.00 and set a
"neutral" rating for the company in a report on Thursday, April 14th.
One investment analyst has rated the stock with a sell rating, nine have issued
a hold rating and seven have given a buy rating to the stock. According to data
from MarketBeat, the company currently has an average rating of
"Hold" and a consensus target price of $246.73. Read
more …
Downgrades:
Edison International (NYSE:EIX) was downgraded by equities researchers at UBS Group from a "buy" rating to a "neutral" rating in a research note issued to investors on Monday, Briefing.com reports. They presently have a $73.00 target price on the utilities provider's stock, down from their previous target price of $75.00. UBS Group's price objective indicates a potential upside of 4.61% from the stock's current price.
Other equities analysts have also issued reports about the
company. Wells Fargo & Company boosted their price target on Edison
International from $70.00 to $79.00 and gave the company an
"overweight" rating in a research note on Wednesday, March 30th.
Morgan Stanley decreased their price objective on Edison International from
$65.00 to $64.00 and set an "equal weight" rating for the company in
a report on Monday, May 23rd. Mizuho downgraded Edison International from a
"buy" rating to a "neutral" rating and decreased their
price objective for the company from $82.00 to $72.00 in a report on Tuesday,
May 10th. Citigroup boosted their price objective on Edison International from
$67.00 to $79.00 in a report on Wednesday, May 4th. Finally, StockNews.com
started coverage on Edison International in a report on Thursday, March 31st.
They set a "hold" rating for the company. Five equities research
analysts have rated the stock with a hold rating and three have given a buy
rating to the company's stock. Based on data from MarketBeat.com, the stock
currently has an average rating of "Hold" and an average target price
of $72.63. Read
more …
Canadian Natural Resources (NYSE:CNQ) (TSE:CNQ) was downgraded by Scotiabank from a "sector outperform" rating to a "sector perform" rating in a report released on Wednesday, Briefing.com reports.
CNQ has been the subject of several other research reports.
Wells Fargo & Company boosted their price target on shares of Canadian
Natural Resources from $61.00 to $79.00 and gave the stock an "equal
weight" rating in a research note on Friday, March 11th. Desjardins
boosted their price target on shares of Canadian Natural Resources from C$75.00
to C$85.00 in a research note on Monday, March 7th. Stifel Nicolaus boosted
their price target on shares of Canadian Natural Resources from C$80.00 to
C$100.00 in a research note on Monday, March 7th. Royal Bank of Canada boosted
their price target on shares of Canadian Natural Resources from C$80.00 to
C$85.00 in a research note on Thursday, March 31st. Finally, The Goldman Sachs
Group lifted their price objective on shares of Canadian Natural Resources from
$64.00 to $72.00 and gave the stock a "neutral" rating in a research
report on Friday, May 20th. Six investment analysts have rated the stock with a
hold rating, nine have assigned a buy rating and one has issued a strong buy
rating to the company. Based on data from MarketBeat.com, Canadian Natural
Resources currently has a consensus rating of "Buy" and a consensus
price target of $78.35. Read
more …
Moody's (NYSE:MCO) was downgraded by research analysts at Atlantic Securities from an "overweight" rating to a "neutral" rating in a note issued to investors on Wednesday, The Fly reports.
Several other equities research analysts have also commented
on MCO. StockNews.com began coverage on shares of Moody's in a research note on
Thursday, March 31st. They issued a "hold" rating on the stock.
Morgan Stanley cut their target price on Moody's from $318.00 to $305.00 and
set an "equal weight" rating on the stock in a research note on
Thursday, June 2nd. Raymond James decreased their price target on Moody's from
$439.00 to $417.00 and set an "outperform" rating for the company in
a research note on Thursday, April 7th. Stifel Nicolaus reduced their price
objective on shares of Moody's from $400.00 to $385.00 and set a
"hold" rating for the company in a report on Friday, March 4th.
Finally, UBS Group lowered their target price on shares of Moody's from $308.00
to $288.00 and set a "neutral" rating on the stock in a research note
on Monday. Seven equities research analysts have rated the stock with a hold
rating and eight have issued a buy rating to the stock. Based on data from
MarketBeat, the stock has a consensus rating of "Buy" and an average
price target of $348.67. Read
more …
Altria Group (NYSE:MO) was downgraded by equities researchers at Morgan Stanley from an "equal weight" rating to an "underweight" rating in a research note issued on Wednesday, The Fly reports. They presently have a $50.00 target price on the stock, down from their prior target price of $54.00. Morgan Stanley's price objective would indicate a potential downside of 7.42% from the company's current price.
Other equities analysts have also recently issued research
reports about the stock. The Goldman Sachs Group upgraded shares of Altria
Group from a "neutral" rating to a "buy" rating and
increased their price objective for the stock from $48.00 to $57.00 in a
research note on Tuesday, March 22nd. StockNews.com assumed coverage on shares
of Altria Group in a research note on Thursday, March 31st. They set a
"buy" rating on the stock. Royal Bank of Canada lowered Altria Group
from an "outperform" rating to a "sector perform" rating
and set a $53.00 price objective for the company. in a research note on Monday,
March 28th. Deutsche Bank Aktiengesellschaft lifted their target price on
Altria Group from $54.00 to $60.00 in a research report on Friday, April 29th.
Finally, Cowen upped their price target on Altria Group from $51.00 to $53.00
in a research report on Thursday, April 7th. One investment analyst has rated
the stock with a sell rating, four have issued a hold rating and three have
issued a buy rating to the company. According to MarketBeat, the stock
presently has an average rating of "Hold" and an average price target
of $53.63. Read
more …
Scotts Miracle-Gro (NYSE:SMG) was downgraded by stock analysts at Truist Financial from a “buy” rating to a “hold” rating in a research note issued on Wednesday, FinViz reports. They presently have a $85.00 price target on the basic materials company’s stock, down from their prior price target of $185.00. Truist Financial’s target price points to a potential downside of 16.81% from the stock’s previous close.
Several other research analysts also recently commented on
SMG. Raymond James reduced their price target on shares of Scotts Miracle-Gro
from $185.00 to $150.00 and set a “strong-buy” rating on the stock in a
research note on Monday, March 14th. Stifel Nicolaus lowered shares of Scotts
Miracle-Gro from a “buy” rating to a “hold” rating and cut their target price
for the company from $130.00 to $116.00 in a report on Wednesday, May 4th.
StockNews.com cut shares of Scotts Miracle-Gro from a “hold” rating to a “sell”
rating in a research note on Saturday, May 21st. JPMorgan Chase & Co.
upgraded shares of Scotts Miracle-Gro from a “neutral” rating to an
“overweight” rating and reduced their price objective for the company from
$150.00 to $130.00 in a report on Wednesday, May 4th. They noted that the move
was a valuation call. Finally, Wells Fargo lowered their price objective on
Scotts Miracle-Gro from $145.00 to $130.00 and set an “overweight” rating for
the company in a research report on Thursday, June 2nd. One analyst has rated
the stock with a sell rating, four have assigned a hold rating, four have
issued a buy rating and one has given a strong buy rating to the stock.
According to MarketBeat, the stock presently has a consensus rating of “Buy”
and a consensus price target of $147.33. Read
more …
Target (NYSE:TGT) was downgraded by investment analysts at Bank of America from a “buy” rating to a “neutral” rating in a research report issued on Wednesday, The Fly reports. They presently have a $165.00 target price on the retailer’s stock, down from their prior target price of $235.00. Bank of America‘s price target would indicate a potential upside of 5.78% from the stock’s previous close.
A number of other research firms also recently issued
reports on TGT. Stifel Nicolaus downgraded Target from a “buy” rating to a
“hold” rating and cut their price target for the company from $270.00 to
$185.00 in a research note on Wednesday, May 18th. Gordon Haskett lowered their
price objective on Target from $300.00 to $200.00 and set a “buy” rating on the
stock in a research report on Thursday, May 19th. Telsey Advisory Group lowered
their price objective on Target from $305.00 to $200.00 and set an “outperform”
rating on the stock in a research report on Thursday, May 19th. Evercore ISI
assumed coverage on Target in a research report on Friday, February 25th. They
set a “hold” rating and a $235.00 price objective on the stock. Finally, BMO
Capital Markets lowered their price objective on Target from $250.00 to $210.00
and set an “outperform” rating on the stock in a research report on Thursday, May
19th. Twelve research analysts have rated the stock with a hold rating,
thirteen have assigned a buy rating and one has given a strong buy rating to
the company’s stock. According to data from MarketBeat.com, the stock currently
has an average rating of “Buy” and an average price target of $214.92. Read
more …
Comments
Post a Comment